News

CancerVAX Announces Research Program

CancerVAX, Inc., a developer of immunotherapy cancer treatments that use the body’s immune system to fight cancer, today announced that it has entered into a sponsored research agreement with UCLA…

CancerVAX Closes Series A Funding Round

CancerVAX, Inc., a developer of immunotherapy cancer treatments that use the body’s immune system to fight cancer, today announced it has closed its $2 million series A funding round…

CancerVAX Launched

CancerVAX, Inc., a developer of immunotherapy cancer treatments that use the body’s immune system to fight cancer, today announced the formation of the Company by Lindsay Mann, an experienced healthcare executive….

Biotech Executive Joins CancerVAX

New CEO Ryan Davies will lead the Company’s development of its breakthrough immunotherapy treatment

CancerVAX Files Provisional Patent for a Universal Cancer Vaccine

The Company plans to leverage cutting-edge CRISPR and mRNA technologies in its quest to develop a breakthrough universal cancer vaccine (UCV).